

[ Mon, Feb 20th 2023
] - WOPRAI

[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
Vikram Purohit Maintained (ASND) at Buy with Increased Target to $151 on, Feb 17th, 2023
Vikram Purohit of Morgan Stanley, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $148 to $151 on, Feb 17th, 2023.
Vikram has made no other calls on ASND in the last 4 months.
There are 5 other peers that have a rating on ASND. Out of the 5 peers that are also analyzing ASND, 0 agree with Vikram's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Vikram
- Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $163 on, Tuesday, January 17th, 2023
- Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $177 on, Tuesday, January 3rd, 2023
- Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $164 on, Monday, November 14th, 2022
- David Lebowitz of "Citigroup" Maintained at Strong Buy with Increased Target to $163 on, Thursday, November 3rd, 2022
- Paul Choi of "Goldman Sachs" Initiated at Strong Buy and Held Target at $174 on, Thursday, October 20th, 2022
Contributing Sources